Feature | October 03, 2013

Accuray Involved in More Than 100 ASTRO Presentations

Data Supports Growing Use of CyberKnife SBRT for Prostate Cancer

radiation therapy radiontherapy cyberknife tomotherapy systems

October 3, 2013 — Accuray Incorporated announced that studies presented at the American Society for Radiation Oncology (ASTRO) 55th Annual Meeting continue to reinforce evidence of clinical and quality of life benefits for the CyberKnife and TomoTherapy Systems.

 

Cyberknife Clinical and Technical Study

The 43 CyberKnife presentations focused on a range of indications including lung, brain, kidney, and prostate stereotactic body radiation therapy (SBRT), which was the topic of 14 presentations. The emphasis on CyberKnife prostate SBRT was timely, given ASTRO’s recently announced update to its model policy on SBRT which states that SBRT is an appropriate alternative for select patients with low to intermediate risk disease.

Two[i] prospective Phase II studies found that the quality of life for patients undergoing CyberKnife SBRT for prostate cancer “compare favorably to published results from radical prostatectomy and intensity-modulated radiation therapy.”

One[ii] study of lung SBRT with the CyberKnife System reported lower chest wall maximum dose when lesions were tracked with the Synchrony Respiratory Tracking System compared to static or linac-based treatment plans, and another study[iii] showed very low incidence of chest wall pain, a common side effect of lung SBRT for lesions near the chest wall.

Three[iv] treatment planning simulation studies incorporating the multileaf collimator of the new CyberKnife M6 System found consistent reductions in treatment time for both radiosurgery and intensity-modulated radiation therapy (IMRT) plans, with equivalent or improved plan quality relative to the prior circular collimator plans or IMRT plans generated for other radiotherapy systems.

 

TomoTherapy Clinical and Technical Study

Of the 61 TomoTherapy presentations, several focused on treatment of breast, head and neck, prostate and lung cancers. The studies showed the breadth and depth of the TomoTherapy system as an efficient treatment option for a wide range of patients and disease types clinically proven to provide strong disease control and low incidence of toxicity.

One[v] notable study showed TomoDirect can be used to deliver hypofractionated whole breast radiotherapy with a simultaneous boost to the resection cavity. Authors concluded TomoDirect was, “…an efficient means to deliver accelerated hypofractionated [treatment]...with an optimal dose distribution, negligible toxicity and encouraging clinical results.”

Another study[vi] presented long-term outcomes of post-operative helical TomoTherapy treatment of malignant pleural mesothelioma. Overall survival was “among the best observed in recent studies, supporting the idea that this approach represents an alternative option to extrapleural pneumonectomy.”

In a related study[vii], authors confirmed in patients with malignant pleural mesothelioma that either adjuvant conventionally fractionated or definitive hypofractionated TomoTherapy treatment results in a high prescription dose to the treatment volume while sparing organs at risk.

A third study[viii] showed that use of VoLO planning, the GPU-based dose calculation system, results in “a considerable saving of time during the calculation process” without significant changes in plan quality.

For more information: www.accuray.com

 

References:  

[i] Chen et al., Quality of Life (QOL) Outcomes Through 3 Years After Stereotactic Body Radiation Therapy (SBRT) for Early Prostate Cancer: Results From a Multi-institutional Phase 2 Trial. 55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013. Meier et al., Patient-Reported Quality of Life Outcomes in Intermediate-Risk Prostate Cancer Patients Treated With Stereotactic Body Radiation Therapy. 55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013.

[ii] Goldin et al., Stereotactic Body Radiation Therapy for Early Stage Lung Cancer: Quantifying the Effect of Tracking With Respiratory Motion on Chest Wall Dosimetry. 55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013.

[iii] Podder et al., Chest Wall and Rib Irradiation of Lung Cancer Patients Treated With Robotic Radiosurgery SBRT. 55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013.

[iv] Kole et al. Improved Normal Tissue Sparing and Reduced Treatment Time Using Multileaf Collimator Robotic Radiosurgery Stereotactic Body Radiation Therapy (SBRT) Compared to Iris Collimator SBRT in Treatment of Localized Prostate Cancer. 55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013. Wang et al. Beam Selection for MLC-Based Robotic Radiation Therapy. 55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013. McGuinness et al., Standard Fractionation IMRT With a MLC-Equipped Robotic Radiosurgery System.  55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013.

[v] Franco et al., Hypofractionated Adjuvant Breast Radiation and Simultaneous Integrated Boost Delivered With Static Angle Tomotherapy: A Prospective Phase 2 Trial. 55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013.

[vi] Trovo et al., Radical Pleurectomy/Decortication Followed by High Dose of Radiation Therapy Delivered With Tomotherapy for Malignant Pleural Mesothelioma: Final Results With Long-term Follow-up. 55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013.

[vii] Parisi et al. Tomotherapy in the Treatment of Malignant Pleural Mesothelioma.  55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013.

[viii] Mohr et al., Accelerated GPU-Based Tomotherapy Planning.  55th Annual American Society for Radiation Oncology (ASTRO) Meeting, Atlanta, Georgia, September 22 – 25, 2013.

 

Related Content

New Method Improves Ability to Measure and Maximize Radiation Therapy Dose
News | Radiation Therapy | May 14, 2019
Delivering just the right dose of radiation for cancer patients is a delicate balance in their treatment regime....
Sponsored Content | Videos | Radiation Oncology | May 13, 2019
At ASTRO 2018, Accuray showcased new patient-fi
Radiotherapy After Chemo May Improve Survival in Advanced Hodgkin's Lymphoma Patients
News | Radiation Therapy | May 10, 2019
Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy...
IBA Partnering to Develop Advanced Digital Proton Therapy Technologies in Belgium
News | Proton Therapy | May 10, 2019
IBA (Ion Beam Applications SA) announced a research agreement with Skandionkliniken, Université Catholique de Louvain...
A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beam will ablate for a noninvasive pulmonary vein isolation procedure. Varian acquires, buys, purchases Cyberheart.

A CyberHeart cardiac ablation radiotherapy treatment plan showing where the radiation beams will ablate for a noninvasive pulmonary vein isolation procedure to treat an arrhythmia.

Feature | Radiation Therapy | May 10, 2019
May 10, 2019 — Radiation oncology vendor Varian announced it acquired the start-up company CyberHeart, which has deve
The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core

The novel nanoparticle is designed to enhance radiation killing of cancer cells in the radiation resistant low-oxygen tumor core. Credit: Wenpei Fan, LOMIN Laboratory, NIBIB.

News | Radiation Therapy | May 08, 2019
Radiation kills tumors by creating oxygen free radicals that damage the tumor DNA. However, the lack of oxygen in the...
Netherlands Proton Therapy Center Delivers First Clinical Flash Irradiation
News | Proton Therapy | May 02, 2019
IBA (Ion Beam Applications SA) recently announced the first Flash irradiation in an IBA proton therapy gantry treatment...
Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018.

Artificial intelligence (AI) was again the hottest topic in radiology, with 11 of the top 20 pieces of content this month relating to AI. These images are a few of the AI technologies highlighted in ITN Editor's Choice video of the most innovative AI technologies highlighted at RSNA 2018. 

Feature | May 01, 2019
May 1, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine webs
Pencil Beam Scanning Better Protects Children With Brain Tumors
News | Proton Therapy | May 01, 2019
A comparison of three types of radiotherapy for children's brain tumors suggests a type of proton therapy called pencil...
Researchers Identify Ways to Predict and Avoid Radiotherapy Side Effects
News | Radiation Therapy | April 30, 2019
New research has shown a combination of biological markers and certain genetic changes can predict radiation...